Clinical Research Directory
Browse clinical research sites, groups, and studies.
hAM for Inferior RRD
Sponsor: Eye & ENT Hospital of Fudan University
Summary
The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.
Official title: Prospective Study on the Use of Human Amniotic Membrane (hAM) in the Treatment of Inferior Rhegmatogenous Retinal Detachment (RRD)
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-08-01
Completion Date
2026-07-31
Last Updated
2025-07-28
Healthy Volunteers
No
Conditions
Interventions
hAM
The hAM stands for human amniotic membrane, which was used to seal inferior retinal breaks after complete vitrectomy.
Locations (1)
EyeEntFudan
Shanghai, Shanghai Municipality, China